Die wissenschaftlichen Aktivitäten des Instituts für Neuropathologie und Neuromolekularpathologie spiegeln sich in Veröffentlichungen in nationalen und internationalen Fachzeitschriften wider. Nachfolgend finden Sie eine Auswahl aktueller Publikationen sowie die ORCID-Profile unserer Wissenschaftler:innen.

ORCID Liste der individuellen Publikationen

Adelheid Wöhrer https://orcid.org/0000-0001-8435-8189

Claudia Manzl https://orcid.org/0000-0001-6269-7585

Matthias Perkonigg https://orcid.org/0000-0002-9107-4755

Alexander Miller-Michlits https://orcid.org/0009-0001-9079-7548

Anna Maria Birkl-Toeglhofer https://orcid.org/0000-0001-6908-145X

Johannes Attems https://orcid.org/0000-0003-1636-1700

Gudrun C. Thalhammer-Thurner https://orcid.org/0000-0003-1592-7856

Glory Ranches https://orcid.org/0000-0002-3623-1746

1. Sex-specific differences in DNA methylation defining prognostically relevant subgroups in glioblastoma.  Barbara Kiesel, Borkovec Martin, Julia Furtner-Srajer, Thomas Roetzer-Pejrimovsky, Karl-Heinz Nenning, Lisa Greutter, Yelyzaveta Miller-Michlits, Georg Widhalm, Adelheid Wöhrer; J Neurosurg 2025. PMID: 39951709; DOI: 10.3171/2024.9.JNS24665
2. Phase 2 precision oncology clinical trial in glioblastoma. Anna Sophie Berghoff, Maximilian J. Mair, Zoltan Spiró, Calvin Abdel Malak, Amin El- Heliebi, Franziska Eckert, Julia Furtner, Franz König, Annette Leibeseder, Martha Nowosielski, Stefan Oberndorfer, Barbara Prietl, Josef Pichler, Thomas R. Pieber, Sabine Spiegl-Kreinecker, Tadeja Urbanic Purkart, Adelheid Wöhrer, Georg Widhalm, Matthias Preusser; in press with Neurooncol. Adv. 2025
3. Predicting critical surgical characteristics of intracranial meningiomas on MRI—A prospective study on 100 consecutive patients. Fabian Winter, Julia Furtner, Astrid Dunst, Gregor Kasprian, Michael Weber, Adelheid Woehrer, Karl Roessler, Christian Dorfer; Neuro-Oncology Practice, 2025;, npaf004, https://doi.org/10.1093/nop/npaf004
4. Alzheimer’s disease neuropathological change in younger individuals with IDH-mutant glioma. Lisa Greutter, Lisa Schnitzenlehner, Sigrid Klotz, Barbara Kiesel, Yelyzaveta Miller-Michlits, Jessica Makoli, Georg Widhalm, Bernhard Baumann, Adelheid Woehrer; Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf057, https://doi.org/10.1093/noajnl/vdaf057
5. Deep learning links localized digital pathology phenotypes with transcriptional subtype and patient outcome in glioblastoma. Thomas Roetzer-Pejrimovsky, Karl-Heinz Nenning, Barbara Kiesel, Johanna Klughammer, Martin Rajchl, Bernhard Baumann, Georg Langs, Adelheid Wöhrer. Gigascience 2024. PMID: 39185700; DOI: 10.1093/gigascience/giae057
6. Analysis of the Porphyrin Peak Shift and Fluorescence Lifetime in Gliomas with Different Tumor Grades, Intratumoral Regions, and Visible Fluorescence Status. Körner, Lisa Irina, David Reichert, Marco Andreana, Angelika Unterhuber, Mikael T. Erkkilae, Jessica Makolli, Barbara Kiesel, Mario Mischkulnig, Thomas Rötzer-Pejrimovsky, Adelheid Wöhrer; Diagnostics 14, no. 23: 2651. https://doi.org/10.3390/diagnostics14232651
7. Tissue clocks derived from histological signatures of biological aging enable tissue-specific aging predictions from blood. Ernesto Abila, Iva Buljan, Yimin Zheng, Tamas Veres, Zhilong Weng, Maja Nackenhorst, Wolfgang Hulla, Yuri Tolkach, Adelheid Wöhrer, André F. Rendeiro. bioRxiv 2024; https://doi.org/10.1101/2024.11.14.618081
8. Frequent Alzheimer’s disease neuropathological change in patients with glioblastoma, Lisa Greutter, Yelyzaveta Miller-Michlits, Sigrid Klotz, Regina Reimann, Karl-Heinz Nenning, Stephan Platzek, Elena Krause, Barbara Kiesel, Georg Widhalm, Georg Langs, Bernhard Baumann, Adelheid Wöhrer. Neurooncol Adv. PMID: 39220249; DOI: 10.1093/noajnl/vdae118
9. Multimodal analytical tools for the molecular and elemental characterisation of lesions in brain tissue of multiple sclerosis patients. Niehaus P, Gonzalez de Vega R, Haindl MT, Birkl C, Leoni M, Birkl-Toeglhofer AM, Haybaeck J, Ropele S, Seeba M, Goessler W, Karst U, Langkammer C, Clases D. PMID:38128277; DOI: 10.1016/j.talanta.2023.125518
10. PROVIT-CLOCK: A Potential Influence of Probiotics and Vitamin B7 Add-On Treatment and Metabolites on Clock Gene Expression in Major Depression. Kreuzer K, Birkl-Toeglhofer AM, Haybaeck J, Reiter A, Dalkner N, Fellendorf FT, Maget A, Platzer M, Seidl M, Mendel LM, Lenger M, Birner A, Queissner R, Mairinger M, Obermayer A, Kohlhammer-Dohr A, Stross TM, Häussl A, Hamm C, Schöggl H, Amberger-Otti D, Painold A, Lahousen-Luxenberger T, Leitner-Afschar B, Färber T, Mörkl S, Wagner-Skacel J, Meier-Allard N, Lackner S, Holasek S, Habisch H, Madl T, Reininghaus E, Bengesser SA; PMID: 38776887; DOI: 10.1159/000538781